GlassScriptPhysician profile
Jennifer Orr
NPI 1538165915
$281.93
in general payments reported to CMS, 2019-2025
11 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.58 · 2020: $19.25 · 2022: $31.06 · 2024: $105 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $45.24 | 2024 | Caplyta |
| Hologic Sales and Service, LLC | $34.98 | 2025 | Aptima |
| Abbvie INC. | $31.45 | 2024-2025 | |
| Novo Nordisk INC | $31.06 | 2022 | |
| Alexion Pharmaceuticals, INC. | $26.54 | 2024 | Strensiq |
| Astrazeneca Pharmaceuticals LP | $22.83 | 2025 | Airsupra |
| Ars Pharmaceuticals Operations, INC. | $21.83 | 2025 | Neffy |
| Sanofi Pasteur INC. | $19.25 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.52 | 2024 | Trintellix |
| Pfizer INC. | $15.65 | 2025 | |
| Agiliti Surgical, INC. | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.